Within- and between-laboratory reproducibility and predictive capacity of amino acid derivative reactivity assay (ADRA) using a 0.5 mg/mL test chemical solution: Results of the study for reproducibility confirmation implemented in five participating laboratories

Yusuke Yamamoto, Masaharu Fujita, Shinichi Watanabe, Hiroaki Yamaga, Koji Wakabayashi, Yu Tahara, Nobuyuki Horie, Keiichi Fujimoto, Kazuya Takeuchi, Kohei Kamiya, Tsuyoshi Kawakami, Kohichi Kojima, Takashi Sozu, Hajime Kojima, Toshihiko Kasahara, Atsushi Ono

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

The amino acid derivative reactivity assay (ADRA) is an in chemico alternative assay for skin sensitization listed in OECD test guideline 442C. ADRA evaluates the reactivity of sensitizers to proteins, which is key event 1 in the skin sensitization adverse outcome pathway. Although the current key event 1 evaluation method is a simple assay that evaluates nucleophile and test chemical reactivity, mixtures of unknown molecular weights cannot be evaluated because a constant molar ratio between the nucleophile and test chemical is necessary. In addition, because the nucleophile is quantified by HPLC, the frequency of co-eluting the test chemical and nucleophile increases when measuring multi-component mixtures. To solve these issues, test conditions have been developed using a 0.5 mg/mL test chemical solution and fluorescence-based detection. Since the practicality of these methods has not been substantiated, a validation test to confirm reproducibility was conducted in this study. The 10 proficiency substances listed in the ADRA guidelines were tested three times at five different laboratories. The results of both within- and between-laboratory reproducibility were 100%, and the results of ultraviolet- and fluorescence-based measurements were also consistent. In addition to the proficiency substances, a new positive control, squaric acid diethyl ester, was tested three times at the five laboratories. The results showed high reproducibility with N-(2-(1-naphthyl)acetyl)-l-cysteine depletion of 37%–52% and α-N-(2-(1-naphthyl)acetyl)-l-lysine depletion of 99%–100%. Thus, high reproducibility was confirmed in both evaluations of the 0.5 mg/mL test chemical and the fluorescence-based measurements, validating the practicability of these methods.

Original languageEnglish
Pages (from-to)1078-1090
Number of pages13
JournalJournal of Applied Toxicology
Volume42
Issue number6
DOIs
Publication statusPublished - Jun 2022

Keywords

  • ADRA (0.5 mg/mL)
  • amino acid derivative reactivity assay
  • between-laboratory reproducibility
  • NAC
  • NAL
  • predictive capacity
  • proficiency substances
  • reproducibility
  • within-laboratory reproducibility

ASJC Scopus subject areas

  • Toxicology

Fingerprint

Dive into the research topics of 'Within- and between-laboratory reproducibility and predictive capacity of amino acid derivative reactivity assay (ADRA) using a 0.5 mg/mL test chemical solution: Results of the study for reproducibility confirmation implemented in five participating laboratories'. Together they form a unique fingerprint.

Cite this